首页> 外文期刊>Nuclearmedicine >C-11-methionine PET/CT after inconclusive Tc-99m-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism
【24h】

C-11-methionine PET/CT after inconclusive Tc-99m-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism

机译:不确定的Tc-99m-MIBI-SPECT / CT后C-11-甲硫氨酸PET / CT对原发性甲状旁腺功能亢进症甲状旁腺腺瘤的定位

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To investigate the efficacy of PET/CT with C-11-methionine for localizing parathyroid adenomas in patients with suspected primary hyperparathyroidism and inconclusive results of cervical ultrasonography and Tc-99m-MIBI-SPECT/CT. Patients, method: Retrospective analysis of imaging data of 18 patients and correlation with clinical outcome, in particular intraoperative findings and histopathology of excised tissue. Results: 12 of 18 patients received surgery. In 10 patients single parathyroid adenomas were found (diameter: 5-20 mm), 2 patients presented parathyroid hyperplasia (5 excised hyperplastic glands (diameter: 2-12 mm). PET/CT correctly localized all adenomas and 1 of 5 hyperplastic glands. The sensitivity per patient was 91.7% (11 of 12), the sensitivity per lesion 73.3% (11 of 15). All lesions missed by; PET/CT had a size smaller than 9 mm and a volume of less than 0.2 ml. In 6 patients no surgery was performed. Five of them had a negative or atypical PET/CT. Further follow-up indicated familial hypocalciuric hypercalcemia in 3 of them (thus, PET/CT true negative), in the remaining 2 patients no validation is available. One patient with 2 highly suggestive lesions rejected surgery so far. Conclusion: PET/CT with C-11-methionine is a very sensitive method for the detection of parathyroid adenomas, even if they are too small to be visualized by Tc-99m-MIBI-SPECT/CT.
机译:目的:探讨PET / CT和C-11-蛋氨酸在可疑原发性甲状旁腺功能亢进症患者中定位甲状旁腺腺瘤的效果,以及宫颈超声和Tc-99m-MIBI-SPECT / CT的不确定性结果。患者,方法:对18例患者的影像数据进行回顾性分析,并与临床结果相关,特别是术中发现的结果和切除组织的组织病理学。结果:18例患者中有12例接受了手术。在10例患者中发现单个甲状旁腺腺瘤(直径:5-20 mm),2例患者出现甲状旁腺增生(5个切除的增生腺体(直径:2-12 mm),PET / CT正确定位了所有腺瘤和5个增生腺体中的1个。每位患者的敏感性为91.7%(12个中的11个),每个病变的敏感性为73.3%(15个中的11个),所有缺失均被漏诊; PET / CT的尺寸小于9 mm,体积小于0.2 ml。 6例未做手术,其中5例PET / CT呈阴性或不典型,进一步的随访表明其中3例家族性低钙血症(因此,PET / CT阴性),其余2例无验证。到目前为止,有2个高度提示性病变的患者拒绝手术。结论:PET / CT结合C-11-甲硫氨酸是检测甲状旁腺腺瘤的一种非常灵敏的方法,即使它们太小而无法通过Tc-99m- MIBI-SPECT / CT。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号